StockpollyBeta
Get App
Popularity #4,343
CELU · NASDAQ · Biotechnology

Celularity (CELU)

Develops placenta-derived cell therapies for longevity and age-related disease.

$1.18
After hours−0.01 (−0.42%)
At close$1.19(−4.44%)

In millions of USD, except per-share figures

In millionsQ1 FY23Mar 2023Q2 FY23Jun 2023Q3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025
Revenue43412151291811654
Cost of revenue214102247452−4
Gross profit220313105118039
664599−112020172018161631
Research & development179510864444353
14131113141613161413915
Selling & marketing000000000000
General & administrative00013000160000
Other expenses352384−132100000212
Operating income−64−42−9913−7−10−12−9−10−16−13−22
0−55−4−154−5−4−9−9−10−2
Interest income000000000000
Interest expense011112222211
Other non-operating income04−62413−5307791
Income before tax−64−48−9410−22−6−16−13−20−25−23−24
Income tax expense000000000000
Net income from continuing operations−64−48−9410−22−6−16−13−20−25−23−24
Net income−64−48−9410−22−6−16−13−20−25−23−24
EPS, basic−$4.12−$2.72−$4.99$0.49−$1.03−$0.30−$0.73−$0.59−$0.84−$1.02−$0.88−$0.95
EPS, diluted−$4.12−$2.72−$4.99$0.49−$1.03−$0.30−$0.73−$0.59−$0.84−$1.02−$0.88−$0.95
Weighted average shares, basic161819192122222224242626
Weighted average shares, diluted161819192122222224242626
EBITDA−61−45−91−9−19−3−12−8−15−21−20−22
Depreciation & amortization222222222222
EBIT−64−47−93−11−21−5−14−9−17−23−22−23